FDA Approves First Quadrivalent, Adjuvanted Flu Vaccine for Older Adults |
Clinical News
eMediNexus Coverage from: 
FDA Approves First Quadrivalent, Adjuvanted Flu Vaccine for Older Adults

1 Read Comments                

The US Food and Drug Administration (FDA) has given approval for the first quadrivalent, adjuvanted influenza vaccine for adults aged 65 years or older for protection against seasonal influenza.

The approval is supported by data from several clinical studies showing the safety and efficacy of the quadrivalent version in adults 65 years or older against influenza strains included in the vaccine… (Medscape)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now